What Are BPC-157, CJC-1295, Ipamorelin, TB-500 and Similar Peptides?
BPC-157, CJC-1295, ipamorelin, and TB-500 are examples of peptides frequently discussed in wellness, bodybuilding, sports-recovery, and “peptide therapy” markets. They are sometimes promoted for muscle growth, recovery, injury healing, hormone signaling, or other health goals.
However, these compounds should not be grouped together as if they have the same effects or regulatory status.
| Peptide | Commonly marketed for | FDA status / evidence |
|---|---|---|
| BPC-157 | Recovery, tissue healing, inflammation | Not FDA-approved; human safety information is limited |
| CJC-1295 | Growth-hormone signaling, muscle/recovery | Not FDA-approved; FDA has identified limited clinical data and safety concerns |
| Ipamorelin | Growth-hormone signaling, muscle/recovery | No FDA-approved drug products containing ipamorelin |
| TB-500 | Recovery, wound/tissue healing | Not FDA-approved; FDA has identified important gaps in human safety information |
The FDA currently identifies BPC-157, CJC-1295, ipamorelin acetate, and TB-500/thymosin beta-4 fragment among substances for which it has raised safety concerns related to issues such as immunogenicity, peptide impurities, characterization, or limited human safety information.
BPC-157
BPC-157 is an experimental peptide that has attracted attention for potential applications involving tissue repair, gastrointestinal health, inflammation, and recovery. Despite extensive discussion online, it is not an FDA-approved drug. In 2026, the FDA specifically evaluated BPC-157-related substances in connection with potential compounding and noted limited safety information.
CJC-1295
CJC-1295 is a synthetic peptide associated with growth-hormone signaling. It is commonly marketed in bodybuilding and wellness settings for muscle development, recovery, or anti-aging purposes. It is not FDA-approved, and the FDA has identified limited clinical data along with reported serious adverse events, including increased heart rate and systemic vasodilatory reactions.
Ipamorelin
Ipamorelin is a growth-hormone secretagogue that has been investigated for conditions including growth-hormone deficiency and postoperative ileus. The FDA has stated that there are no FDA-approved drug products containing ipamorelin, despite its availability through some wellness and compounding channels.
The FDA has also raised concerns about immunogenicity and peptide-related impurities and has noted limited safety information for certain injectable routes.
TB-500
TB-500 generally refers to a fragment of thymosin beta-4 and is commonly promoted for wound healing, tissue repair, and recovery. It is not an FDA-approved drug. FDA materials note that it has limited human exposure data and potential concerns involving immunogenicity and peptide-related impurities.
Are These Peptides the Same as FDA-Approved Peptide Medicines?
No. This distinction is particularly important.
The fact that a peptide is available from a compounding pharmacy or wellness clinic does not mean that the FDA has approved it. FDA states that compounded drugs are not FDA-approved and that the agency does not verify their safety, effectiveness, or quality before they are marketed.
BPC-157, CJC-1295, ipamorelin, TB-500, BPC-157 benefits, CJC-1295 benefits, ipamorelin benefits, TB-500 benefits, BPC-157 safety, CJC-1295 safety, ipamorelin safety, TB-500 safety, FDA approved peptides, peptide therapy, recovery peptides, muscle growth peptides, research peptides, peptides for recovery, BPC-157 FDA approved, CJC-1295 FDA approved, ipamorelin FDA approved, TB-500 FDA approved, peptide FAQ